Literature DB >> 28217978

The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction.

Matthew Nayor1,2, Martin G Larson1,3, Na Wang4, Rajalakshmi Santhanakrishnan5, Douglas S Lee6,7, Connie W Tsao1,8, Susan Cheng1,2, Emelia J Benjamin1,9, Ramachandran S Vasan1,9, Daniel Levy1,10, Caroline S Fox1,10,11, Jennifer E Ho1,12.   

Abstract

AIMS: Chronic kidney disease (CKD) and microalbuminuria are associated with incident heart failure (HF), but their relative contributions to HF with preserved vs. reduced EF (HFpEF and HFrEF) are unknown. We sought to evaluate the associations of CKD and microalbuminuria with incident HF subtypes in the community-based Framingham Heart Study (FHS). METHODS AND
RESULTS: We defined CKD as glomerular filtration rate <60 mL/min/1.73 m2 , and microalbuminuria as a urine albumin to creatinine ratio (UACR) ≥17 mg/g in men and ≥25 mg/g in women. We observed 754 HF events (324 HFpEF/326 HFrEF/104 unclassified) among 9889 FHS participants with serum creatinine measured (follow-up 13 ± 4 years). In Cox models adjusted for clinical risk factors, CKD (prevalence = 9%) was associated with overall HF [hazard ratio (HR) 1.24, 95% confidence interval (CI) 1.01-1.51], but was not significantly associated with individual HF subtypes. Among 2912 individuals with available UACR (follow-up 15 ± 4 years), 192 HF events (91 HFpEF/93 HFrEF/8 unclassified) occurred. Microalbuminuria (prevalence = 17%) was associated with a higher risk of overall HF (HR 1.71, 95% CI 1.25-2.34) and HFrEF (HR 2.10, 95% CI 1.35-3.26), but not HFpEF (HR 1.26, 95% CI 0.78-2.03). In cross-sectional analyses, microalbuminuria was associated with LV systolic dysfunction (odds ratio 3.19, 95% CI 1.67-6.09).
CONCLUSIONS: Microalbuminuria was associated with incident HFrEF prospectively, and with LV systolic dysfunction cross-sectionally in a community-based sample. In contrast, CKD was modestly associated with overall HF but not differentially associated with HFpEF vs. HFrEF. The mechanisms responsible for the relationship of microalbuminuria to future development of HFrEF warrant further investigation.
© 2017 The Authors. European Journal of Heart Failure © 2017 European Society of Cardiology.

Entities:  

Keywords:  Cardiorenal syndrome; Epidemiology; Heart failure; Kidney disease; Microalbuminuria; Prevention

Mesh:

Substances:

Year:  2017        PMID: 28217978      PMCID: PMC5423843          DOI: 10.1002/ejhf.778

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  51 in total

Review 1.  Cardiorenal syndrome: new perspectives.

Authors:  Jeremy S Bock; Stephen S Gottlieb
Journal:  Circulation       Date:  2010-06-15       Impact factor: 29.690

2.  Classification of heart failure in population based research: an assessment of six heart failure scores.

Authors:  A Mosterd; J W Deckers; A W Hoes; A Nederpel; A Smeets; D T Linker; D E Grobbee
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

3.  Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study.

Authors:  R B D'Agostino; M L Lee; A J Belanger; L A Cupples; K Anderson; W B Kannel
Journal:  Stat Med       Date:  1990-12       Impact factor: 2.373

4.  Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals.

Authors:  Linda F Fried; Michael G Shlipak; Casey Crump; Anthony J Bleyer; John S Gottdiener; Richard A Kronmal; Lewis H Kuller; Anne B Newman
Journal:  J Am Coll Cardiol       Date:  2003-04-16       Impact factor: 24.094

5.  Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study.

Authors:  R B Devereux; M J Roman; J E Liu; T K Welty; E T Lee; R Rodeheffer; R R Fabsitz; B V Howard
Journal:  Am J Cardiol       Date:  2000-11-15       Impact factor: 2.778

Review 6.  Influence of chronic kidney disease on cardiac structure and function.

Authors:  Kunihiro Matsushita; Shoshana H Ballew; Josef Coresh
Journal:  Curr Hypertens Rep       Date:  2015-09       Impact factor: 5.369

7.  Diagnostic accuracy of clinical criteria for identifying systolic and diastolic heart failure: cross-sectional study.

Authors:  Ana Maestre; Vicente Gil; Javier Gallego; José Aznar; Antonia Mora; Alberto Martín-Hidalgo
Journal:  J Eval Clin Pract       Date:  2009-02       Impact factor: 2.431

8.  Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction.

Authors:  Erin D Unger; Ruth F Dubin; Rajat Deo; Vistasp Daruwalla; Julie L Friedman; Crystal Medina; Lauren Beussink; Benjamin H Freed; Sanjiv J Shah
Journal:  Eur J Heart Fail       Date:  2015-12-03       Impact factor: 15.534

Review 9.  Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis.

Authors:  Kevin Damman; Mattia A E Valente; Adriaan A Voors; Christopher M O'Connor; Dirk J van Veldhuisen; Hans L Hillege
Journal:  Eur Heart J       Date:  2013-10-27       Impact factor: 29.983

Review 10.  Proteinuria and its relation to cardiovascular disease.

Authors:  Gemma Currie; Christian Delles
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-12-21
View more
  9 in total

1.  Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease.

Authors:  Nisha Bansal; Leila Zelnick; Zeenat Bhat; Mirela Dobre; Jiang He; James Lash; Bernard Jaar; Rupal Mehta; Dominic Raj; Hernan Rincon-Choles; Milda Saunders; Sarah Schrauben; Matthew Weir; Julie Wright; Alan S Go
Journal:  J Am Coll Cardiol       Date:  2019-06-04       Impact factor: 24.094

Review 2.  Medical Management of Heart Failure With Reduced Ejection Fraction in Patients With Advanced Renal Disease.

Authors:  Aaron M Hein; Julia J Scialla; Daniel Edmonston; Lauren B Cooper; Adam D DeVore; Robert J Mentz
Journal:  JACC Heart Fail       Date:  2019-05       Impact factor: 12.035

3.  Abnormalities in Cardiac Structure and Function among Individuals with CKD: The COMBINE Trial.

Authors:  Ann A Wang; Xuan Cai; Anand Srivastava; Pottumarthi V Prasad; Stuart M Sprague; James Carr; Myles Wolf; Joachim H Ix; Geoffrey A Block; Michel Chonchol; Kalani L Raphael; Alfred K Cheung; Dominic S Raj; Jennifer J Gassman; Amir Ali Rahsepar; John P Middleton; Linda F Fried; Roberto Sarnari; Tamara Isakova; Rupal Mehta
Journal:  Kidney360       Date:  2021-11-18

4.  Association of Urine Albumin Excretion With Incident Heart Failure Hospitalization in Community-Dwelling Adults.

Authors:  Luke N Bailey; Emily B Levitan; Suzanne E Judd; Madeline R Sterling; Parag Goyal; Mary Cushman; Monika M Safford; Orlando M Gutiérrez
Journal:  JACC Heart Fail       Date:  2019-05       Impact factor: 12.035

5.  New treatments for hyperkalaemia: clinical use in cardiology.

Authors:  Shilpa Vijayakumar; Javed Butler; Stefan D Anker
Journal:  Eur Heart J Suppl       Date:  2019-02-26       Impact factor: 1.803

Review 6.  Highlights in heart failure.

Authors:  Daniela Tomasoni; Marianna Adamo; Carlo Mario Lombardi; Marco Metra
Journal:  ESC Heart Fail       Date:  2019-12

Review 7.  Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease.

Authors:  Milton Packer; Carolyn S P Lam; Lars H Lund; Mathew S Maurer; Barry A Borlaug
Journal:  Eur J Heart Fail       Date:  2020-06-26       Impact factor: 15.534

8.  Microalbuminuria and its Prognostic Significance in Patients with Acute Heart Failure with Preserved, Mid-Range, and Reduced Ejection Fraction.

Authors:  Ömer Doğan Alataş; Murat Biteker; Ahmet Demir; Birdal Yıldırım; Ethem Acar; Kemal Gökçek; Aysel Gökçek
Journal:  Arq Bras Cardiol       Date:  2022-04       Impact factor: 2.000

9.  Anemia has an impact on prognosis in heart failure with preserved ejection fraction with mild chronic kidney disease.

Authors:  Keisuke Okuno; Yoshiro Naito; Masanori Asakura; Masataka Sugahara; Tetsuo Horimatsu; Seiki Yasumura; Saki Tahara; Toshiyuki Nagai; Yoshihiko Saito; Tsutomu Yoshikawa; Tohru Masuyama; Masaharu Ishihara; Toshihisa Anzai
Journal:  Int J Cardiol Heart Vasc       Date:  2021-05-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.